Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 772 Jul 12 – Oct 9, 2026
- Disclosed funding
- $67.1B 615 disclosed amounts
- Median round
- $22.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| CT Crystalys TherapeuticsCompany profile Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout | $130M | Series B | Biotech | United States | Investors | |
| NB N-Zyme BiomedicalCompany profile Developing first-in-class therapies targeting pepsin for reflux disease Developing first-in-class therapies targeting pepsin for reflux disease | $4.6M | Series A | Biotech | United States | Investors Undisclosed | |
| HE Health EndeavorsCompany profile Health Endeavors provides AI-driven care management tools for accountable care organizations Health Endeavors provides AI-driven care management tools for accountable care organizations | Undisclosed | Growth | Healthtech | United States | Investors | |
| PL Petra LabsCompany profile End-to-end AEO partner for enterprise brands, combining software with hands-on execution End-to-end AEO partner for enterprise brands, combining software with hands-on execution | $5.2M | Seed | Enterprise software | United States | Investors | |
| C CascadeCompany profile Platform to help architecture, engineering, and construction firms find and win projects Platform to help architecture, engineering, and construction firms find and win projects | $3.5M | Seed | Proptech | United States | Investors | |
| IL Inner LogicCompany profile Simulates how procedural devices perform across virtual patients before clinical deployment Simulates how procedural devices perform across virtual patients before clinical deployment | $11.5M | Seed | Healthtech | United States | Investors | |
| S StrongestLayerCompany profile AI-native email security company that detects and stops advanced phishing and business email compromise attacks AI-native email security company that detects and stops advanced phishing and business email compromise attacks | $4.1M | Seed+Seed | Cybersecurity | United States | Investors | |
| P Building next-generation AI agent hardware for sports scenarios | Undisclosed | Pre-SeedPre-seed | Consumer | United States | Investors | |
| S Develops and manufactures advanced battery solutions for critical industries | $300M | Growth | Climate tech | United States | Investors | |
| A AlocityCompany profile A conversational interface connecting building access, video, visitors and intercom workflows. A conversational interface connecting building access, video, visitors and intercom workflows. | Undisclosed | Series A | Enterprise software | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 12, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
55rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
40rounds15led - 3Khosla Ventures
Arena, Vinci, Conway Research
25rounds5led - 4Sequoia Capital
TypeSafe AI, Mecka, Healthleap
23rounds5led - 5Insight Partners
Stuut, Hestus, Inc., Quartermaster
21rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.